These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4146390)

  • 1. The central and peripheral activities of anti-acetylcholine drugs. Some concepts of practical relevance.
    Inch TD; Green DM; Thompson PB
    J Pharm Pharmacol; 1973 May; 25(5):359-70. PubMed ID: 4146390
    [No Abstract]   [Full Text] [Related]  

  • 2. The peripheral and central actions of some anticholinergic substances.
    Brimblecombe RW; Green DM
    Int J Neuropharmacol; 1968 Jan; 7(1):15-21. PubMed ID: 5639303
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antimuscarinic action of parkinsonism drugs on peripheral structures and correlation with central efficacy or clinical dosage].
    Oelszner W; Walther H; Wagner U
    Acta Biol Med Ger; 1971; 26(5):1045-59. PubMed ID: 5145608
    [No Abstract]   [Full Text] [Related]  

  • 4. The significance of differences in the potency of enantiomers of anti-acetylcholine drugs.
    Brimblecombe RW; Green DM; Inch TD; Thompson PB
    J Pharm Pharmacol; 1971 Oct; 23(10):745-57. PubMed ID: 4399909
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological properties of oxotremorine and its analogs.
    Ringdahl B; Jenden DJ
    Life Sci; 1983 May; 32(21):2401-13. PubMed ID: 6343743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylene compounds of potential pharmacological value. 18. N-(t-aminoalkynyl)-substituted 2-pyrrolidones, a new series of potent oxotremorine antagonists.
    Lindgren S; Lindquist A; Lindeke B; Svensson U; Karlén B; Dahlbom R
    Acta Pharm Suec; 1973 Dec; 10(6):435-40. PubMed ID: 4773112
    [No Abstract]   [Full Text] [Related]  

  • 7. Central and peripheral anticholinergic potency of some drugs antagonistic to anticholinesterase poisoning.
    Madill HD; Stewart WC; Savoie ML
    Can J Physiol Pharmacol; 1968 Jul; 46(4):559-65. PubMed ID: 5668200
    [No Abstract]   [Full Text] [Related]  

  • 8. Central and peripheral effects of muscarinic cholinergic blocking agents in man.
    Domino EF; Corssen G
    Anesthesiology; 1967; 28(3):568-74. PubMed ID: 6023527
    [No Abstract]   [Full Text] [Related]  

  • 9. [Comparison between the anti-muscarinic and ganglion blocking activities of several atropine-like drugs].
    Kumada S; Ono T; Yamaguchi I; Otsuka M
    Nihon Yakurigaku Zasshi; 1970; 66(6):607-17. PubMed ID: 4395348
    [No Abstract]   [Full Text] [Related]  

  • 10. Investigation of the mechanism of action of oxotremorine on the guinea-pig isolated ileum preparation.
    Cox B; Hecker SE
    Br J Pharmacol; 1971 Jan; 41(1):19-25. PubMed ID: 5547759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Some initial animal and human pharmacological studies with benapryzine (BRL 1288).
    Brown DM; Hughes BO; Marsden CD; Meadows JC; Spicer B
    Br J Pharmacol; 1973 Mar; 47(3):476-86. PubMed ID: 4581246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacological activities of 1,1-diethyl-2-methyl-3-diphenylmethylenepyrrolidinium bromide (pyrodifenium bromide).
    Kumada S; Hitomi M
    Jpn J Pharmacol; 1967 Mar; 17(1):90-104. PubMed ID: 5299979
    [No Abstract]   [Full Text] [Related]  

  • 13. Central and peripheral actions of the acetylcholine antagonist, ambutonium bromide.
    Southgate PJ
    Arch Int Pharmacodyn Ther; 1972 Apr; 196(2):376-82. PubMed ID: 4401084
    [No Abstract]   [Full Text] [Related]  

  • 14. On the interaction of drugs with the cholinergic nervous system--IV. Tolerance to oxotremorine in mice: in vivo and in vitro studies.
    Maayani S; Egozi Y; Pinchasi I; Sokolovsky M
    Biochem Pharmacol; 1977 Sep; 26(18):1681-7. PubMed ID: 901587
    [No Abstract]   [Full Text] [Related]  

  • 15. Central and peripheral actions of anticholinergic drugs when administered with triflupromazine.
    Brimblecombe RW; Green DM; Aldous FA; Thompson PB
    Neuropharmacology; 1971 Jan; 10(1):93-101. PubMed ID: 5569310
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacodynamics of 2-(4-benzyl-piperidino)-1-(4-hydroxyphenyl)-1-propanol (Ifenprodil). (3) Effects on the autonomic, peripheral and central nervous systems].
    Mizusawa H; Yamane M; Sakai K
    Nihon Yakurigaku Zasshi; 1976 Mar; 72(2):185-99. PubMed ID: 987966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects of N-methyl-hyoscine methyl sulfate (DD-234 or 1290 CERM) upon the gastrointestinal motility and salivation].
    Hukuhara T; Fukuda H; Nakayama S; Neya T; Tsuchiya K
    Nihon Heikatsukin Gakkai Zasshi; 1970 Dec; 6(4):263-9. PubMed ID: 4395992
    [No Abstract]   [Full Text] [Related]  

  • 18. [On the pharmacology of the thymoleptic noxiptilin (Bay 1521)].
    Hoffmeister F; Wuttke W; Kroneberg G
    Arzneimittelforschung; 1969 Jun; 19():Suppl 5a:846+. PubMed ID: 5819764
    [No Abstract]   [Full Text] [Related]  

  • 19. Oxotremorine antagonism by a hypothalamic hormone, melanocyte-stimulating hormone release-inhibiting factor (MIF).
    Plotnikoff NP; Kastin AJ; Anderson MS; Schally AV
    Proc Soc Exp Biol Med; 1972 Jul; 140(3):811-4. PubMed ID: 5064701
    [No Abstract]   [Full Text] [Related]  

  • 20. Stereospecificity of oxotremorine antagonists.
    Dahlbom R; Lindquist A; Lindgren S; Svensson U; Ringdahl B; Blair MR
    Experientia; 1974 Oct; 30(10):1165-7. PubMed ID: 4435124
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.